Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jolimark Holdings ( (HK:2028) ) has shared an announcement.
Jolimark Holdings has warned investors that it expects to post a narrowed annual loss of between RMB48 million and RMB55 million for the year ended 31 December 2025, compared with a loss of about RMB60.3 million a year earlier. The company attributes the continued losses mainly to weaker printer demand amid the wider adoption of electronic invoicing, the early-stage rollout of its medical equipment product line, and provisions for asset impairment.
The figures are based on unaudited management accounts, and the final results are due by the end of March 2026, meaning the actual loss may differ from the current estimate. The profit warning underscores the structural headwinds facing Jolimark’s legacy printing business and highlights execution risk around its transition into medical equipment, prompting the board to urge shareholders and potential investors to exercise caution when trading the company’s shares.
The most recent analyst rating on (HK:2028) stock is a Hold with a HK$0.11 price target. To see the full list of analyst forecasts on Jolimark Holdings stock, see the HK:2028 Stock Forecast page.
More about Jolimark Holdings
Jolimark Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands and engaged in the printer market and related equipment businesses. The group has also been expanding into medical equipment products, which are currently in a promotional stage, suggesting a diversification effort beyond its traditional printing-focused operations.
YTD Price Performance: 62.03%
Average Trading Volume: 755,468
Technical Sentiment Signal: Hold
Current Market Cap: HK$78.45M
For a thorough assessment of 2028 stock, go to TipRanks’ Stock Analysis page.